NCCC's
leading pancreatic cancer research experts highlight groundbreaking research projects and clinical trials underway for this challenging cancer, and offer thoughts on what the future holds.
Not exact matches
In addition to providing a new tool for diagnoses, the
research may also
lead to new insights into how
pancreatic cancer arises.
A
research group at Boston's Massachusetts General Hospital,
led by Tayyaba Hasan, has used nanocells and photodynamic therapy (light - activated chemicals) to target
pancreatic cancer.
«As someone who
researches pancreatic cancer, I think this discovery is significant because it defines mechanisms that lead to this cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
cancer, I think this discovery is significant because it defines mechanisms that
lead to this
cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
cancer in ways that we didn't know about before,» says Firpo, who's also a member of the Pancreas
Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman Cancer Inst
Cancer Research Program and Experimental Therapeutics Program at the University of Utah's Huntsman
Cancer Inst
Cancer Institute.
In previous
research, the Banerjees discovered that a particular protein, CCN1, is overexpressed in
pancreatic cancer, which
leads to tumor formation.
«Potential
pancreatic cancer target challenged: New
research finds PDX1 critical for
cancer growth, but blocking it may
lead to more aggressive tumors.»
The quest to improve survival of children with a high - risk brain tumor has
led St. Jude Children's
Research Hospital investigators to two drugs already used to treat adults with breast,
pancreatic, lung and other
cancers.
«Considering that Florida ranks second in the number of
pancreatic cancer deaths that occur each year and the fact that
pancreatic cancer is projected to surpass breast, prostate, and colorectal
cancer and become the second
leading cause of
cancer deaths by 2030, we are thrilled that our state is committed to investing in
pancreatic cancer research now,» said Permuth - Wey.
Together, these
leading cancer research organizations will attract new collaborators; improve diagnosis of
pancreatic cancer using big data; find new treatments for
pancreatic cancer; and support the next generation of
pancreatic cancer investigators.
Building on the successful outcomes of their multi-year history, these
leading cancer research organizations will inspire new collaborators; improve diagnosis of
pancreatic cancer using big data; develop new treatments for
pancreatic cancer; and support the next generation of
pancreatic cancer investigators.
But Christine was also in the right place at Rhode Island Hospital because our Lifespan
Cancer Institute has done remarkable research that has led to promising treatments for pancreatic cancer pat
Cancer Institute has done remarkable
research that has
led to promising treatments for
pancreatic cancer pat
cancer patients.
Penn Medicine's
Pancreatic Cancer Research Center is a leading edge, translational research program that combines basic science research and clinical invest
Research Center is a
leading edge, translational
research program that combines basic science research and clinical invest
research program that combines basic science
research and clinical invest
research and clinical investigation.
An Australian -
led international
research effort has revealed that genetic changes normally linked to breast, colon and ovarian
cancers could also drive a rare form of
pancreatic cancer.
B) «
Led research team of 14 people studying
pancreatic cancer cells, achieving 40 % success rate in X, Y, and Z» (not being a
cancer researcher, I can't finish that sentence)